Skip to main content
Top
Published in: AIDS and Behavior 9/2019

01-09-2019 | Human Immunodeficiency Virus | Original Paper

Effectiveness of a Viral Load Suppression Intervention for Highly Vulnerable People Living with HIV

Authors: Toorjo Ghose, Virginia Shubert, Vaty Poitevien, Sambuddha Choudhuri, Robert Gross

Published in: AIDS and Behavior | Issue 9/2019

Login to get access

Abstract

We examine the effect of the Undetectables Intervention (UI) on viral loads among socially vulnerable HIV-positive clients. The UI utilized a toolkit that included financial incentives, graphic novels, and community-based case management services. A pre-post repeated measures analysis (n = 502) through 4 years examined longitudinal effects of the intervention. Logistic models regressed social determinants on viral loads. Finally, in-depth qualitative interviews (n = 30) examined how UI shaped adherence. The proportion of virally suppressed time-points increased 15% (from 67 to 82% pre to post-enrollment, p < 0.0001). The proportion of the sample virally suppressed at all time-points increased by 23% (from 39 to 62% pre to post-enrollment, p < 0.0001). African Americans and the homeless were the most likely to be unsuppressed at baseline, but, along with substance users, benefitted the most from UI. The intervention shaped adherence through two pathways, by: (1) establishing worth around adherence, and (2) increasing motivation to become suppressed, and maintain adherence.
Literature
1.
go back to reference Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRef Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.CrossRef
2.
go back to reference Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–81.CrossRef Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–81.CrossRef
3.
go back to reference Aidala AA, Wilson MG, Shubert V, et al. Housing status, medical care, and health outcomes among people living with HIV/AIDS: a systematic review. Am J Public Health. 2016;106(1):e1–23.CrossRef Aidala AA, Wilson MG, Shubert V, et al. Housing status, medical care, and health outcomes among people living with HIV/AIDS: a systematic review. Am J Public Health. 2016;106(1):e1–23.CrossRef
4.
go back to reference Feller DJ, Agins BD. Understanding determinants of racial and ethnic disparities in viral load suppression. J Int Assoc Provid AIDS Care. 2017;16(1):23–9.CrossRef Feller DJ, Agins BD. Understanding determinants of racial and ethnic disparities in viral load suppression. J Int Assoc Provid AIDS Care. 2017;16(1):23–9.CrossRef
5.
go back to reference Palepu A, Milloy MJ, Kerr T, Zhang R, Wood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health. 2011;88(3):545–55.CrossRef Palepu A, Milloy MJ, Kerr T, Zhang R, Wood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health. 2011;88(3):545–55.CrossRef
6.
go back to reference Feldman MB, Alexy ER, Thomas JA, Gambone GF, Irvine MK. The association between food insufficiency and HIV treatment outcomes in a longitudinal analysis of HIV-infected individuals in New York City. J Acquir Immune Defic Syndr. 2015;69(3):329–37.CrossRef Feldman MB, Alexy ER, Thomas JA, Gambone GF, Irvine MK. The association between food insufficiency and HIV treatment outcomes in a longitudinal analysis of HIV-infected individuals in New York City. J Acquir Immune Defic Syndr. 2015;69(3):329–37.CrossRef
7.
go back to reference Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav. 2014;8(Suppl 5):S505–15.CrossRef Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav. 2014;8(Suppl 5):S505–15.CrossRef
8.
go back to reference Joseph B, Kerr T, Puskas CM, Montaner J, Wood E, Milloy MJ. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care. 2015;27(9):1128–36.CrossRef Joseph B, Kerr T, Puskas CM, Montaner J, Wood E, Milloy MJ. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care. 2015;27(9):1128–36.CrossRef
9.
go back to reference Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14.CrossRef Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14.CrossRef
10.
go back to reference Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16(5):767–74.CrossRef Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16(5):767–74.CrossRef
11.
go back to reference Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care. 2017;29(4):418–22.CrossRef Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care. 2017;29(4):418–22.CrossRef
12.
go back to reference Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother. 2009;63(4):636–40.CrossRef Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother. 2009;63(4):636–40.CrossRef
13.
go back to reference Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med. 2008;70(5):531–8.CrossRef Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med. 2008;70(5):531–8.CrossRef
14.
go back to reference Robbins GK, Daniels B, Zheng H, et al. Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr. 2007;44(1):30–7.CrossRef Robbins GK, Daniels B, Zheng H, et al. Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr. 2007;44(1):30–7.CrossRef
15.
go back to reference Weiser SD, Hatcher A, Frongillo EA, et al. Food insecurity is associated with greater acute care utilization among HIV-infected homeless and marginally housed individuals in San Francisco. J Gen Intern Med. 2012;28(1):91–8.CrossRef Weiser SD, Hatcher A, Frongillo EA, et al. Food insecurity is associated with greater acute care utilization among HIV-infected homeless and marginally housed individuals in San Francisco. J Gen Intern Med. 2012;28(1):91–8.CrossRef
16.
go back to reference Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2007;44(2):159–66.CrossRef Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2007;44(2):159–66.CrossRef
17.
go back to reference Auerbach JD, Parkhurst JO, Cáceres CF. Addressing social drivers of HIV/AIDS for the long-term response: conceptual and methodological considerations. Glob Public Health. 2011;6(Suppl 3):S293–309.CrossRef Auerbach JD, Parkhurst JO, Cáceres CF. Addressing social drivers of HIV/AIDS for the long-term response: conceptual and methodological considerations. Glob Public Health. 2011;6(Suppl 3):S293–309.CrossRef
18.
go back to reference Adimora AA, Auerbach JD. Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S132–5.CrossRef Adimora AA, Auerbach JD. Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S132–5.CrossRef
19.
go back to reference Brown JL, Vanable PA. Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature. Ann Behav Med. 2008;35(1):26–40.CrossRef Brown JL, Vanable PA. Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature. Ann Behav Med. 2008;35(1):26–40.CrossRef
20.
go back to reference Olem D, Sharp KM, Taylor JM, Johnson MO. Overcoming barriers to HIV treatment adherence: a brief cognitive behavioral intervention for HIV-positive adults on antiretroviral treatment. Cogn Behav Pract. 2014;21(2):206–23.CrossRef Olem D, Sharp KM, Taylor JM, Johnson MO. Overcoming barriers to HIV treatment adherence: a brief cognitive behavioral intervention for HIV-positive adults on antiretroviral treatment. Cogn Behav Pract. 2014;21(2):206–23.CrossRef
21.
go back to reference Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.CrossRef Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.CrossRef
22.
go back to reference Gwadz M, Cleland CM, Applegate E, et al. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav. 2015;19(10):1801–17.CrossRef Gwadz M, Cleland CM, Applegate E, et al. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav. 2015;19(10):1801–17.CrossRef
23.
go back to reference Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Aquir Immune Defic Syndr. 2007;46(4):443–50.CrossRef Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Aquir Immune Defic Syndr. 2007;46(4):443–50.CrossRef
24.
go back to reference Brennan-Ing M, Seidel L, Rodgers L, et al. The impact of comprehensive case management on HIV client outcomes. PLoS ONE. 2016;11(2):e0148865.CrossRef Brennan-Ing M, Seidel L, Rodgers L, et al. The impact of comprehensive case management on HIV client outcomes. PLoS ONE. 2016;11(2):e0148865.CrossRef
25.
go back to reference Kushel MB, Colfax G, Ragland K, Heineman A, Palacio H, Bangsberg DR. Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis. 2006;43(2):234–42.CrossRef Kushel MB, Colfax G, Ragland K, Heineman A, Palacio H, Bangsberg DR. Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis. 2006;43(2):234–42.CrossRef
26.
go back to reference Irvine MK, Chamberlin SA, Robbins RS, et al. Improvements in HIV Care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program. Clin Infect Dis. 2015;60:298–310.CrossRef Irvine MK, Chamberlin SA, Robbins RS, et al. Improvements in HIV Care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program. Clin Infect Dis. 2015;60:298–310.CrossRef
27.
go back to reference Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–7.CrossRef Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–7.CrossRef
28.
go back to reference de Lima IC, Galvão MTG, de Oliveira Alexandre H, Lima FET, de Araújo TL. Information and communication technologies for adherence to antiretroviral treatment in adults with HIV/AIDS. Int J Med Inform. 2016;92:54–61.CrossRef de Lima IC, Galvão MTG, de Oliveira Alexandre H, Lima FET, de Araújo TL. Information and communication technologies for adherence to antiretroviral treatment in adults with HIV/AIDS. Int J Med Inform. 2016;92:54–61.CrossRef
29.
go back to reference Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.CrossRef Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.CrossRef
30.
go back to reference Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS. 2009;23(8):603–9.CrossRef Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS. 2009;23(8):603–9.CrossRef
31.
go back to reference Sutherland K, Christianson JB, Leatherman S. Impact of targeted financial incentives on personal health behavior: a review of the literature. Med Care Res Rev. 2008;65(6 Suppl):36S–78S.CrossRef Sutherland K, Christianson JB, Leatherman S. Impact of targeted financial incentives on personal health behavior: a review of the literature. Med Care Res Rev. 2008;65(6 Suppl):36S–78S.CrossRef
32.
go back to reference Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888–96.CrossRef Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888–96.CrossRef
33.
go back to reference Taylor NK, Buttenheim AM. Improving utilization of and retention in PMTCT services: can behavioral economics help? BMC Health Serv Res. 2013;13:406.CrossRef Taylor NK, Buttenheim AM. Improving utilization of and retention in PMTCT services: can behavioral economics help? BMC Health Serv Res. 2013;13:406.CrossRef
34.
go back to reference Adamson B, El-Sadr W, Dimitrov D, et al. The cost-effectiveness of financial incentives for viral suppression: HPTN 065 Study. Value Health. 2019;22(2):194–202.CrossRef Adamson B, El-Sadr W, Dimitrov D, et al. The cost-effectiveness of financial incentives for viral suppression: HPTN 065 Study. Value Health. 2019;22(2):194–202.CrossRef
35.
go back to reference Bassett IV, Wilson D, Taaffe J, Freedberg KA. Financial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS. 2015;10(6):451–63.CrossRef Bassett IV, Wilson D, Taaffe J, Freedberg KA. Financial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS. 2015;10(6):451–63.CrossRef
36.
go back to reference DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;55(Suppl):S86–94.CrossRef DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;55(Suppl):S86–94.CrossRef
37.
go back to reference El-Sadr WM, Donnell D, Beauchamp G, et al. Financial incentives for linkage to care and viral suppression among HIV-positive patients: a randomized clinical trial (HPTN 065). JAMA Intern Med. 2017;177(8):1083–92.CrossRef El-Sadr WM, Donnell D, Beauchamp G, et al. Financial incentives for linkage to care and viral suppression among HIV-positive patients: a randomized clinical trial (HPTN 065). JAMA Intern Med. 2017;177(8):1083–92.CrossRef
38.
go back to reference Metsch LR, Feaster DJ, Gooden L, et al. Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial. JAMA. 2016;316(2):156–70.CrossRef Metsch LR, Feaster DJ, Gooden L, et al. Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial. JAMA. 2016;316(2):156–70.CrossRef
39.
go back to reference Farber S, Tate J, Frank C, et al. A study of financial incentives to reduce plasma HIV RNA among patients in care. AIDS Behav. 2013;17(7):2293–300.CrossRef Farber S, Tate J, Frank C, et al. A study of financial incentives to reduce plasma HIV RNA among patients in care. AIDS Behav. 2013;17(7):2293–300.CrossRef
40.
go back to reference Author. The effects of financial incentives on viral load suppression among homeless people with HIV. International AIDS Conference, Durban South Africa (2016) Author. The effects of financial incentives on viral load suppression among homeless people with HIV. International AIDS Conference, Durban South Africa (2016)
41.
go back to reference Author. The Undetectables intervention at Housing Works. Report submitted to the Robin Hood Foundation, New York City, pp. 1–25 (2017). Author. The Undetectables intervention at Housing Works. Report submitted to the Robin Hood Foundation, New York City, pp. 1–25 (2017).
42.
go back to reference Montano DE, Kasprzyk D. Theory of reasoned action, theory of planned behavior, and the integrated behavior model. In: Glanz K, Rimer BK, Vishwanath K, editors. Health behavior and health education. San Francisco: Jossey-Bas; 2008. p. 67–96. Montano DE, Kasprzyk D. Theory of reasoned action, theory of planned behavior, and the integrated behavior model. In: Glanz K, Rimer BK, Vishwanath K, editors. Health behavior and health education. San Francisco: Jossey-Bas; 2008. p. 67–96.
44.
go back to reference Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59–82.CrossRef Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59–82.CrossRef
45.
go back to reference Cole SR, Napravnik Mugavero MJ, Lau B, Eron JJ Jr, Saag MS. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol. 2010;71(2):198–205.CrossRef Cole SR, Napravnik Mugavero MJ, Lau B, Eron JJ Jr, Saag MS. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol. 2010;71(2):198–205.CrossRef
46.
go back to reference NVivo Qualitative Data Analysis Software. QSR International Pty Ltd. Version 10, 2012. NVivo Qualitative Data Analysis Software. QSR International Pty Ltd. Version 10, 2012.
47.
go back to reference Bowen GA. Grounded theory and sensitizing concepts. Int J Qual Methods. 2006;5(3):12–23.CrossRef Bowen GA. Grounded theory and sensitizing concepts. Int J Qual Methods. 2006;5(3):12–23.CrossRef
48.
go back to reference Padgett DK. Coming of age: theoretical thinking, social responsibility, and a global perspective in qualitative research. In: Padgett DK, editor. The qualitative research experience. Belmont: Wadsworth/Thomson Learning; 2004. p. 297–315. Padgett DK. Coming of age: theoretical thinking, social responsibility, and a global perspective in qualitative research. In: Padgett DK, editor. The qualitative research experience. Belmont: Wadsworth/Thomson Learning; 2004. p. 297–315.
49.
go back to reference Campbell JL, Quicy C, Osserman J. Coding in-depth semi-structured interviews: problems of unitization and intercoder reliability and agreement. Sociol Methods Res. 2013;42(3):294–320.CrossRef Campbell JL, Quicy C, Osserman J. Coding in-depth semi-structured interviews: problems of unitization and intercoder reliability and agreement. Sociol Methods Res. 2013;42(3):294–320.CrossRef
50.
go back to reference Krippendorff K. Content analysis: an introduction to its methodology. 2nd ed. Thousand Oaks: Sage; 2004. p. 2004. Krippendorff K. Content analysis: an introduction to its methodology. 2nd ed. Thousand Oaks: Sage; 2004. p. 2004.
Metadata
Title
Effectiveness of a Viral Load Suppression Intervention for Highly Vulnerable People Living with HIV
Authors
Toorjo Ghose
Virginia Shubert
Vaty Poitevien
Sambuddha Choudhuri
Robert Gross
Publication date
01-09-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02509-5

Other articles of this Issue 9/2019

AIDS and Behavior 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.